Efficacy of botulinum toxin A treatment in a case of pantothenate kinase associated neurodegeneration (PKAN).
Neurorehabilitation Department, Clinic Center, Napoli, Italy. claudiocrisci@live.it
Claudio
C
Crisci
Marcello
M
Esposito
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A